Shereen Keleg
Impact in
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Papers in
-
- Hedgehog Signaling Pathway Studies 8
- Epigenetics and DNA Methylation 4
- TGF-β signaling in diseases 2
- Fibroblast Growth Factor Research 2
- Oncology 13
- Pancreatic and Hepatic Oncology Research 11
- Cancer Cells and Metastasis 4
- Co-authors
- Markus W. Büchler (11 shared papers)Jörg Kleeff (14 shared papers)Hany Kayed (14 shared papers)Helmut Frieß (7 shared papers)Thomas Giese (12 shared papers)Helmut Friess (8 shared papers)Peter Büchler (1 shared paper)Roman Ludwig (1 shared paper)
- Journals
- PLoS ONE (3 papers)International Journal of Cancer (3 papers)Pancreas (3 papers)Molecular Cancer (2 papers)Cancer Letters (1 paper)
- Partner nations
- GermanyUnited StatesHungary
In The Last Decade
Shereen Keleg
20 papers receiving 904 citations
Peers
Comparison fields: 5 of 68
- Oncology 371
- Cancer Research 148
- Molecular Biology 504
- Immunology and Allergy 28
- Cell Biology 70
Countries citing papers authored by Shereen Keleg
This map shows the geographic impact of Shereen Keleg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shereen Keleg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shereen Keleg more than expected).
Fields of papers citing papers by Shereen Keleg
This network shows the impact of papers produced by Shereen Keleg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shereen Keleg. The network helps show where Shereen Keleg may publish in the future.
Co-authors
The 25 scholars most cited alongside Shereen Keleg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 181 | |
| 2 | 2004 | 95 | |
| 3 | 2007 | 79 | |
| 4 | 2007 | 72 | |
| 5 | 2005 | 59 | |
| 6 | 2006 | 59 | |
| 7 | 2007 | 58 | |
| 8 | Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells. | 2006 | 48 |
| 9 | 2003 | 44 | |
| 10 | 2009 | 40 | |
| 11 | 2012 | 37 | |
| 12 | 2006 | 36 | |
| 13 | 2005 | 26 | |
| 14 | 2007 | 23 | |
| 15 | 2014 | 22 | |
| 16 | 2009 | 16 | |
| 17 | 2006 | 13 | |
| 18 | 2011 | 9 | |
| 19 | 2008 | 4 | |
| 20 | 2004 | 2 |
About Shereen Keleg
Shereen Keleg is a scholar working on Molecular Biology, Oncology, Cancer Research, Rheumatology and Surgery, having authored 20 papers that have together received 923 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (11 papers), Hedgehog Signaling Pathway Studies (8 papers), Epigenetics and DNA Methylation (4 papers), Cancer Cells and Metastasis (4 papers), Cancer Genomics and Diagnostics (2 papers), Bone and Dental Protein Studies (2 papers), TGF-β signaling in diseases (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Oncology (371 citations), Cancer Research (148 citations), Molecular Biology (504 citations), Immunology and Allergy (28 citations) and Cell Biology (70 citations). Shereen Keleg has collaborated with scholars based in Germany, United States and Hungary. Frequent co-authors include Markus W. Büchler, Jörg Kleeff, Hany Kayed, Helmut Frieß, Thomas Giese, Helmut Friess, Peter Büchler, Roman Ludwig, Iréne Esposito and Nathalia A. Giese. Their work appears in journals such as PLoS ONE, International Journal of Cancer, Pancreas, Molecular Cancer and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.